We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multivariable Diagnostic Prediction Score Validated for Leptospirosis

By LabMedica International staff writers
Posted on 30 Jan 2020
Leptospirosis is a bacterial disease that affects humans and animals. More...
It is caused by bacteria of the genus Leptospira. In humans, it can cause a wide range of symptoms, some of which may be mistaken for other diseases.

Diagnosing leptospirosis is a clinical obstacle, as clinical presentations are similar to other infectious diseases. Available serological tests are often insensitive and not cost-effective. Many clinical diagnostic scorings had been developed, but most were based on hospitalized patients, and would not be suitable for use in suspected patients in setting of ambulatory care.

Clinical scientists at Mahidol University (Salaya, Thailand) and their colleagues performed a prospective, multisite diagnostic prediction study with development of a diagnostic score (OPD). The development cohort was based on patients suspicious of leptospirosis who visited five community hospitals in Si Sa Ket province, Thailand during December 2017 to November 2018. Leptospirosis confirmed cases were defined when one of the three standard confirmatory tests was positive.

The first set of blood samples were sent for blood culture, real time polymerase chain reaction (PCR) and microscopic agglutination test (MAT). Patients were also scheduled for another visit for the second blood samples collection, which would be used as a paired serum to evaluate rising of MAT. For direct culture of Leptospira, a drop of blood and urine was separately inoculated into 4 mL of liquid Ellinghausen-McCullough-Johnson-Harris (EMJH) at 29 ⁰C for 14 days. Detection for Leptospira was done with direct observation via dark field microscopy. The team confirmed all isolation of Leptospira by performing 16S rRNA sequencing.

The team enrolled a total of 262 leptospirosis suspicious patients. Eighty-two patients (31.5%) were leptospirosis confirmed cases. Five final predictors remained within the reduced logistic model which were history of exposure to wet ground at workplace, history of contact water reservoir used by animal, urine protein and urine blood positive from dipstick test, and neutrophil count from complete blood count (CBC) ≥80%. The OPD score diagnostic performance was area under the receiver operating characteristic curve (AuROC = 0.72). Test of equality revealed significant differences of AuROC between the OPD and WHO score (0.72 versus 0.62). Patients were categorized into low and high probability of having leptospirosis at score point of 3.5 with sensitivity 72.4% and specificity 61.7%.

The authors concluded that their study had developed and internally validated the OPD Lepto Score, a practical clinical risk score for the diagnosis of leptospirosis in suspected patients with acute undifferentiated fever who presented to the outpatient clinics in high endemic areas. With five predictors, the score was more practical for outpatient setting than the conventional WHO score with 10 predictors. The study was published on January 9, 2020 in the journal PLOS Neglected Tropical Diseases.

Related Links:
Mahidol University


Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.